Alkylating agents: Platinum analogs Nitrogen Mustards Carboplatin

Slides:



Advertisements
Similar presentations
Cytidine analogue ALL, AML
Advertisements

Anticancer Agents Antibiotics Classification of Antibiotics:
Cancer Detection and Diagnosis Early Cancer May Not Have Any symptoms Pap Test Mammograms Blood tests Prostate-specific antigen (PSA) Carcinoembryonic.
Cancer Cancer accounted for 7.1 million deaths world-wide (12.5%). Ranks as 3 of the top 10 leading causes of death world wide. 11 million are diagnosed.
Antineoplastic Agents Cell Cycle Specific (CCS) AgentsCell Cycle Non-Specific (CCNS) Agents Plant alkaloids and antimetabolites Alkylating agents and some.
Basic and Clinical Pharmacology Dr. J.M.Nguta, BVM, MSc, PhD, Pharmacol & Toxicol (UON). Notes available at:
Nucleic Acid Metabolism Robert F. Waters, PhD
Nucleic acids metabolism
Indications: MANY: Malignant lymphomas, mycosis fungoides and leukemias; several non-malignant diseases: severe rheumatoid arthritis and systemic lupus.
Pharmacology of Chemotherapy
MICROTEACHING Sanjeev Sharma
Pharmacology of Antineoplastic Agents 1 Outline of Lecture Topics: 1.Background 2.Antineoplastic Agents a. Cell Cycle Specific (CCS) b. Cell Cycle Non-Specific.
Chapter 49 Antineoplastic Drugs Department of pharmacology Liu xiaokang( 刘小康) 2010,3.
Cancer Chemotherapy Topics
Understanding the cell cycle - chemotherapy and beyond
CANCER CHEMOTHERAPY. General Principles of Action of Anticancer Drugs A. Treatment strategies B. Treatment regimens and scheduling C. Problems associated.
Chemotherapy of Medulloblastoma By: Minh Trinh. Objectives Briefly describe chemotherapy of medulloblastoma Discuss different regimens used for therapy.
Cancer therapy - conventional Surgery Radiotherapy Chemotherapy Adjuvant therapies.
Zenaida N. Maglaya, MD, FPSECP
Cancer Drug Classes The classes of drugs currently used in the cancer clinic are  1. DNA Binding Agents (intercalating and alkylating.
II- Antimetabolites.
Anti-cancer compounds / Antineoplastic Agents, chapter 38 Neoplasm: New and diseased form of tissue growth Benign (godartet) neoplasm: Easy to separate.
Chapter 54 Cancer Chemotherapy
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Pharmacology in Nursing Antineoplastic Drugs Part 1: Cancer.
By: Dr. Abdulaziz Bin Saeedan Ph.D. Department of Pharmacology E mail: P harmacology – IV PHL-425 Chapter 2: CANCER CHEMOTHERAPY:
Cancer therapeutic drugs
I. Alkylating Agents & Related Compounds
Anticancer Drugs Dr.Qamar Barakzai Department of Pharmacology Ziauddin Medical University Karachi.Pakistan.
Principles of Chemotherapy. Objectives At the completion of this session the participant will be able to: ◦ Define combination chemotherapy ◦ Recognize.
Gout Familial metabolic disease characterized by : Acute arthritis Uric acid stones in the kidneys Hyperuricemia.
Learning Objectives: Nucleic Acid therapeutics ReadingChapter 4, p from Blackburn & Gait Know the general mechanisms of the anti-cancer drugs.
Hyper CVAD (First Arm) DaysDoseDrug Days 1, 2, and 3300mg/m 2 IV over 3 hours Q12H x 6 doses Cyclophosphamide Day 450mg/ m 2 IV Doxorubicin Days 4 and.
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 20 Antineoplastic.
The Practical Side of Nucleotide Metabolism November 29, 2001.
ONCOLOGY Cytotoxic Agents. ONCOLOGY Cytotoxic agents Selective toxicity based on characteristics that distinguish malignant cells from normal cells Antineoplastic.
Principles of Chemotherapy and Chemotherapy Complications Özlem Sönmez, MD Yeditepe University Hospital Section of Medical Oncology.
Clinical Division of Oncology Department of Medicine I Medical University of Vienna, Austria Cytotoxic Agents.
Antineoplastics 1 February :08 AM.
1 By: Abdulaziz bin Saeedan P h.D. Department of Pharmacology E mail: P harmacology – IV PHL-425 Chapter 3: CANCER CHEMOTHERAPY.
Cancer Chemotherapy Dr.Azarm.  The goal of cancer treatment is eradication of cancer  If not possible shifts to palliation,amelioration and preservation.
Anticancer Drugs General Pharmacology M212 Dr. Laila M. Matalqah Ph.D. Pharmacology.
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 101 Anticancer Drugs I: Cytotoxic Agents.
Therapy of cancer disease This study material is recommended specifically for practical courses from Pharmacology II for students of general medicine and.
Anticancer & Immunosupressants Q.. Questions 1-3. For each of the following statements, select the most appropriate drug which is BEST characterized by.
University of Kerbala College of veterinary medicine Pharmacology Lect. # 4 Antineoplastic Drugs Dr. Sattar K. Abdul-Hussain, PhD, DVM, DABT.
Anticancer Drugs. Introduction Cancer refers to a malignant neoplasm or new growth. Cancer cells manifest uncontrolled proliferation, loss of function.
一、general information antineoplastic agents
UNIVERSITY OF LUSAKA CANCER CHEMOTHERAPY.
Cancer Chemotherapy OUTLINE
Anti-cancer compounds / Antineoplastic Agents, chapter 38
Cancer Chemotherapy and immunosupressants
Anti- CANCER drugs Dr. Mohammed Abd-Almoneim
Pharmacology of Antineoplastic Agents
Microtubule inhibitors
Anticancer drugs.
Pyrimidine metabolism
Patients on Chemotherapy
Alkylating agents.
Cancer treatment and chemotherapy
Antineoplastic Prescribing I
Anti-cancer treatment טיפול בסרטן
School of Pharmacy, University of Nizwa
Laurence J. Egan, M.B., William J. Sandborn, M.D 
School of Pharmacy, University of Nizwa
Histopathology Pharmacology Review
ANTIMETABOLITES Antimetabolites are structurally related to normal compounds that exist within the cell They generally interfere with the availability.
Section I Basic Pharmacology of Anticancer Drug
Laurence J. Egan, M.B., William J. Sandborn, M.D 
Patrick: An Introduction to Medicinal Chemistry 6e
OBJECTIVES To learn the mechanism of cytotoxicity and toxicity of the commonly used antimetabolites.
Presentation transcript:

Alkylating agents: Platinum analogs Nitrogen Mustards Carboplatin Cisplatin Oxaliplatin Triazenes Dacarbazine Procarbazine Temozolomide Nitrogen Mustards Bendamustine Cyclophosphamide Estramustine Ifosfamide Mechlorethamine Melphalan

Miscellaneous 13) Busulfan 14) Chlorambucil 15) Lomustine

Alkylating agents Nitrosoureas -Transfer alkyl group to cellular elements Alkylation of DNA Drug – Cyclization – ethyleimonium ion – transfer alkyl group to DNA Nitrosoureas -Carbamoylation of lysine of proteins -Single strand or both strands – BIFUNCTIONAL

Pharmacological effects : -DNA Strand breakage Cross linking of DNA CCNS. Mostly in late G1 & S Pharmacological effects : Dose related ADR. On rapidly growing tissue Carinogenic – Secondary esp. AML VESICANT

CYCLOPHOSPHAMIDE NITROSOUREAS: Not cross resistant with other alkylating agents Enter BBB- lipid soluble – Brain tumors Oral administration STREPTOZOCIN

ADR Acrolein is the metabolite Responsible for causing hemorrhagic cystitis Suprapubic pain Hematuria Cyctoscopic findings ***This is prevented/treated by MESNA (mercaptoethanesulfonate) Rarely cyclophosphamide can cause SIADH and pulmonary toxicity

NON CLASSICAL ALKYLATING AGENTS: PROCARBAZINE: Hodgkin's, Non – Hodgkin's, Brain -Microsomal enzymes – azoprocarbazine + H2O2 One metabolite – weak MAOI Increase risk of secondary cancer

DACARBAZINE Activation in liver  monomethyl derivative  diazomethane,  methyl Carbonium ion  cytotoxic Malignant melanoma, HL, Soft tissue sarcomas, neuroblastoma. Potent vesicant

BENDAMUSTINE: Bi functional PLATINUM ANALOGS: Cisplatin Carboplatin Oxatiplatin -Kill cells in all stage of cell cycle -Synergism with alkylating agents, fluoropyrimidines & taxanes. -vigorous hydration – Renal toxicity.

-Oxaliplatin + 5-FU + leucovorin – FOLFOX regimen – metastatic colorectal cancer - Severe nausea & vomiting Neurotoxicity- dose limiting.

Trimetrexate Pemetrexed Cytarabine Thioguanine Gemcitabine Capecitabine Thioguanine Fludarabine Phosphate Cladribine

Anti metabolites: Folate antag:- Methotrexate Pemetrexed Punine analogs:- 3) Cladribine 4) Clofarabine 5) Fludarabine 6) Mercaptopurine 7) Pentostatin Pyramiding analogs. 8) Azacitidine 9) Capecitabine 10) Cytarabine 11) Decitabine 12) Fluorouracil 13) Gemcitabine

Antimetabolits: sites of drug action

Methotrexate (MTX) MTX is a folic acid analog that binds with high affinity to the active catalytic site of dihydrofolate reductase (DHFR) Thus it interferes with the synthesis of tetrahydrofolate (THF) THF serves as the key one-carbon carrier for enzymatic processes involved in de novo synthesis of thymidylate, purine nucleotides, and the amino acids serine and methionine. Inhibition of these various metabolic processes thereby interferes with the formation of DNA, RNA, and key cellular proteins.

Mechanism of Resistance 1. Decreased drug transport 2. Altered DHFR 3. Decreased polyglutamate formation 4. Increased levels of DHFR

Contd.. Most commonly used anticancer drug. Cell cycle specific (CCS) drug and acts during S phase of the cell cycle. Antineoplastic, immunosuppressant and antiinflammatory Used in RA, psoriasis Well absorbed orally; can also be given IM, IV or intrathecally**. It is bound to plasma proteins, does not cross the BBB and most of the drug is excreted unchanged in urine. It is a weak acid and so is excreted better at high urine pH. Appropriate hydration and alkalinizing the urine is important to prevent renal tox with MTX

Leucovorin Rescue Mechanism of action of methotrexate and the effect of administration of leucovorin. FH2 = dihydrofolate FH4 = tetrahydrofolate dTMP = deoxythymidine monophosphate dUMP = deoxyuridine mono phosphate.

Anti-metabolites:- Methotrexate:- Mechanism of action Leucovorin rescue Resistance:- Uses:- ALL, Choric cancer , Burkitt's, breast cancer, Head & Neck Cancer Inflammatory diseases PR:- Intrathecal – Pharmacological sanctuary ADR:- Renal damage, Cirrhosis, Pulmonary infiltrates

2) 6 – MP:- Azathioprine – 6MP PK:- DI MOA Allopurinol 3) 6 – TG – Purine Analog Acute nonlymhocytic leukemia + daunorubicin + Cytarbine 6 – TG  HGPRT TGMP  di & tri PO4 Θ Biosynthesis of Purines Cancer abc admin by allopurinol

4) Fludarabime:- CLL, hairy cell leukemia, indolent NHL high doses – encephalopathy, blindness and death. 5) Hairy cell leukemia, CLL, NHL

Enzyme inhibitors Anthracy clines Damorubicin Doxorubicin Epirubicin Idraubicin Mitoxantrone Topoismerase inhibitors Etoposide Irinotecarn Topotecam

Anthracy clines Inhibit topoisornerase High –affinity binding to DNA through intercalation – blockade of synthesis of DNA & RNA, & DNA strand scission Generation of Seniquinone & O2 free radicals though Fe dependent process Binding to cellular membranes to alter fluidity & non tram sport

Doxorubicin - Used in Many Cancer Carditoxi city -  Acute  Chronic  DEXRAZOXANE “ Radiation recall reaction”